326 related articles for article (PubMed ID: 11162604)
21. Smad3 differently affects osteoblast differentiation depending upon its differentiation stage.
Kaji H; Naito J; Sowa H; Sugimoto T; Chihara K
Horm Metab Res; 2006 Nov; 38(11):740-5. PubMed ID: 17111301
[TBL] [Abstract][Full Text] [Related]
22. Suppressive effect of regucalcin on cell differentiation and mineralization in osteoblastic MC3T3-E1 cells.
Yamaguchi M; Kobayashi M; Uchiyama S
J Cell Biochem; 2005 Oct; 96(3):543-54. PubMed ID: 16052480
[TBL] [Abstract][Full Text] [Related]
23. [Effect of simvastatin on bone morphogenetic protein-2 expression and alkaline phosphatase activity of bone marrow stromal cell].
Song CL; Dang GT; Guo ZQ
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2002 Nov; 16(6):384-7. PubMed ID: 12508427
[TBL] [Abstract][Full Text] [Related]
24. Cartilage-derived morphogenetic proteins enhance the osteogenic protein-1-induced osteoblastic cell differentiation of C2C12 cells.
Yeh LC; Tsai AD; Zavala MC; Lee JC
J Cell Physiol; 2004 Dec; 201(3):401-8. PubMed ID: 15389555
[TBL] [Abstract][Full Text] [Related]
25. Metformin enhances the differentiation and mineralization of osteoblastic MC3T3-E1 cells via AMP kinase activation as well as eNOS and BMP-2 expression.
Kanazawa I; Yamaguchi T; Yano S; Yamauchi M; Sugimoto T
Biochem Biophys Res Commun; 2008 Oct; 375(3):414-9. PubMed ID: 18721796
[TBL] [Abstract][Full Text] [Related]
26. Enhancement of osteoblastic differentiation of mesenchymal stromal cells cultured by selective combination of bone morphogenetic protein-2 (BMP-2) and fibroblast growth factor-2 (FGF-2).
Maegawa N; Kawamura K; Hirose M; Yajima H; Takakura Y; Ohgushi H
J Tissue Eng Regen Med; 2007; 1(4):306-13. PubMed ID: 18038421
[TBL] [Abstract][Full Text] [Related]
27. Sanguis Draconis resin stimulates osteoblast alkaline phosphatase activity and mineralization in MC3T3-E1 cells.
Wang W; Olson D; Cheng B; Guo X; Wang K
J Ethnopharmacol; 2012 Jun; 142(1):168-74. PubMed ID: 22543168
[TBL] [Abstract][Full Text] [Related]
28. Stimulatory effects of statins on bone marrow-derived mesenchymal stem cells. Study of a new therapeutic agent for fracture.
Sonobe M; Hattori K; Tomita N; Yoshikawa T; Aoki H; Takakura Y; Suguro T
Biomed Mater Eng; 2005; 15(4):261-7. PubMed ID: 16010034
[TBL] [Abstract][Full Text] [Related]
29. Osteoclast inhibitory lectin (OCIL) inhibits osteoblast differentiation and function in vitro.
Nakamura A; Ly C; Cipetić M; Sims NA; Vieusseux J; Kartsogiannis V; Bouralexis S; Saleh H; Zhou H; Price JT; Martin TJ; Ng KW; Gillespie MT; Quinn JM
Bone; 2007 Feb; 40(2):305-15. PubMed ID: 17049328
[TBL] [Abstract][Full Text] [Related]
30. Constitutive expression of thrombospondin 1 in MC3T3-E1 osteoblastic cells inhibits mineralization.
Ueno A; Miwa Y; Miyoshi K; Horiguchi T; Inoue H; Ruspita I; Abe K; Yamashita K; Hayashi E; Noma T
J Cell Physiol; 2006 Nov; 209(2):322-32. PubMed ID: 16883596
[TBL] [Abstract][Full Text] [Related]
31. Early osteoblastic differentiation induced by dexamethasone enhances adenoviral gene delivery to marrow stromal cells.
Blum JS; Parrott MB; Mikos AG; Barry MA
J Orthop Res; 2004 Mar; 22(2):411-6. PubMed ID: 15013104
[TBL] [Abstract][Full Text] [Related]
32. Statins and bone metabolism.
Horiuchi N; Maeda T
Oral Dis; 2006 Mar; 12(2):85-101. PubMed ID: 16476028
[TBL] [Abstract][Full Text] [Related]
33. Oxysterol-induced osteoblastic differentiation of pluripotent mesenchymal cells is mediated through a PKC- and PKA-dependent pathway.
Richardson JA; Amantea CM; Kianmahd B; Tetradis S; Lieberman JR; Hahn TJ; Parhami F
J Cell Biochem; 2007 Apr; 100(5):1131-45. PubMed ID: 17031848
[TBL] [Abstract][Full Text] [Related]
34. Methotrexate (MTX) inhibits osteoblastic differentiation in vitro: possible mechanism of MTX osteopathy.
Uehara R; Suzuki Y; Ichikawa Y
J Rheumatol; 2001 Feb; 28(2):251-6. PubMed ID: 11246658
[TBL] [Abstract][Full Text] [Related]
35. Bone morphogenetic protein-2 counterregulates interleukin-18 mRNA and protein in MC3T3-E1 mouse osteoblastic cells.
Hori M; Sawai H; Tsuji Y; Okamura H; Koyama K
Connect Tissue Res; 2006; 47(3):124-32. PubMed ID: 16753805
[TBL] [Abstract][Full Text] [Related]
36. The effect of statins in colorectal cancer is mediated through the bone morphogenetic protein pathway.
Kodach LL; Bleuming SA; Peppelenbosch MP; Hommes DW; van den Brink GR; Hardwick JC
Gastroenterology; 2007 Oct; 133(4):1272-81. PubMed ID: 17919499
[TBL] [Abstract][Full Text] [Related]
37. Role of the cholesterol biosynthetic pathway in osteoblastic differentiation of marrow stromal cells.
Parhami F; Mody N; Gharavi N; Ballard AJ; Tintut Y; Demer LL
J Bone Miner Res; 2002 Nov; 17(11):1997-2003. PubMed ID: 12412807
[TBL] [Abstract][Full Text] [Related]
38. Role of serum in the developmental expression of alkaline phosphatase in MC3T3-E1 osteoblasts.
Yohay DA; Zhang J; Thrailkill KM; Arthur JM; Quarles LD
J Cell Physiol; 1994 Mar; 158(3):467-75. PubMed ID: 8126070
[TBL] [Abstract][Full Text] [Related]
39. Involvement of phosphodiesterase isozymes in osteoblastic differentiation.
Wakabayashi S; Tsutsumimoto T; Kawasaki S; Kinoshita T; Horiuchi H; Takaoka K
J Bone Miner Res; 2002 Feb; 17(2):249-56. PubMed ID: 11811555
[TBL] [Abstract][Full Text] [Related]
40. Parathyroid hormone enhances bone morphogenetic protein activity by increasing intracellular 3', 5'-cyclic adenosine monophosphate accumulation in osteoblastic MC3T3-E1 cells.
Nakao Y; Koike T; Ohta Y; Manaka T; Imai Y; Takaoka K
Bone; 2009 May; 44(5):872-7. PubMed ID: 19442611
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
